Pharmaceuticals, Biotechnology and Life Sciences
Interest in large-scale Linear DNA for nucleic acid-based therapies continues to rise STONY BROOK, N.Y.–(BUSINESS WIRE)–$apdn #alzheimers–LineaRx, Inc. a wholly-owned…
MADISON, Wis.–(BUSINESS WIRE)–#CSR–Promega Corporation, a global biotechnology manufacturer, today announced publication of its annual Corporate Responsibility Report of sustainable practices…
DUBLIN–(BUSINESS WIRE)–The “Combination Anti-diabetes Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Depressive Disorders: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. The Depressive…
Global 4WHIM trial marks first-ever Phase 3 study in patients with WHIM syndrome CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq:XFOR), a…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
LONDON–(BUSINESS WIRE)–#CompetitiveIntelligence–A well-known market intelligence company, Infiniti Research, has announced the completion of their recent article on the pharmaceutical industry…
DUBLIN–(BUSINESS WIRE)–The “Kymriah” report has been added to ResearchAndMarkets.com’s offering. Kymriah (tisagenlecleucel; Novartis) is a cluster of differentiation (CD)19-targeted genetically…
Veravas, Inc., an emerging diagnostic company, appointed eight members to its Advisory Board
DUBLIN–(BUSINESS WIRE)–The “Fotivda” report has been added to ResearchAndMarkets.com’s offering. Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) is an oral…